Zakera Shums

2.8k total citations
57 papers, 1.6k citations indexed

About

Zakera Shums is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Zakera Shums has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 22 papers in Epidemiology and 21 papers in Rheumatology. Recurrent topics in Zakera Shums's work include Liver Diseases and Immunity (23 papers), Systemic Lupus Erythematosus Research (19 papers) and Liver Disease Diagnosis and Treatment (16 papers). Zakera Shums is often cited by papers focused on Liver Diseases and Immunity (23 papers), Systemic Lupus Erythematosus Research (19 papers) and Liver Disease Diagnosis and Treatment (16 papers). Zakera Shums collaborates with scholars based in United States, Hungary and Italy. Zakera Shums's co-authors include Gary L. Norman, Albert J. Czaja, Susan Encabo, Mária Papp, Walter L. Binder, Aldo J. Montaño‐Loza, Carola Severi, Bruno Annibale, Piotr Milkiewicz and Edith Lahner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Zakera Shums

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zakera Shums United States 25 704 674 577 414 341 57 1.6k
Catherine Johanet France 28 1.5k 2.1× 1.6k 2.4× 614 1.1× 733 1.8× 177 0.5× 105 2.5k
Dominique Cazals‐Hatem France 19 337 0.5× 440 0.7× 236 0.4× 696 1.7× 165 0.5× 49 1.7k
Giuseppe Monti Italy 19 366 0.5× 594 0.9× 333 0.6× 224 0.5× 80 0.2× 56 1.2k
Marcella Visentini Italy 21 346 0.5× 445 0.7× 347 0.6× 177 0.4× 242 0.7× 67 1.8k
Allison Luo United States 13 307 0.4× 60 0.1× 343 0.6× 131 0.3× 348 1.0× 30 1.0k
Laura Gragnani Italy 24 829 1.2× 1.3k 1.9× 513 0.9× 185 0.4× 94 0.3× 84 2.0k
Ibtissem Ghédira Tunisia 18 241 0.3× 63 0.1× 276 0.5× 161 0.4× 160 0.5× 70 885
Vaidehi Chowdhary United States 18 257 0.4× 123 0.2× 503 0.9× 151 0.4× 60 0.2× 42 936
Juan Putra United States 17 356 0.5× 578 0.9× 76 0.1× 403 1.0× 89 0.3× 67 1.9k
J R Goepel United Kingdom 22 413 0.6× 357 0.5× 61 0.1× 554 1.3× 128 0.4× 65 1.7k

Countries citing papers authored by Zakera Shums

Since Specialization
Citations

This map shows the geographic impact of Zakera Shums's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zakera Shums with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zakera Shums more than expected).

Fields of papers citing papers by Zakera Shums

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zakera Shums. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zakera Shums. The network helps show where Zakera Shums may publish in the future.

Co-authorship network of co-authors of Zakera Shums

This figure shows the co-authorship network connecting the top 25 collaborators of Zakera Shums. A scholar is included among the top collaborators of Zakera Shums based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zakera Shums. Zakera Shums is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kovács, György, Nóra Sipeki, Tamás Tornai, et al.. (2018). Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients. PLoS ONE. 13(3). e0194166–e0194166. 21 indexed citations
2.
Kuś, Aleksander, Konrad Szymañski, Ewa Wunsch, et al.. (2017). Genetic Risk Factors for Autoimmune Thyroid Disease might Affect the Susceptibility to and Modulate the Progression of Primary Biliary Cholangitis. Journal of Gastrointestinal and Liver Diseases. 26(3). 245–252. 8 indexed citations
3.
Tornai, Tamás, Zsuzsanna Vitális, István Tornai, et al.. (2017). Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. World Journal of Gastroenterology. 23(29). 5412–5412. 37 indexed citations
4.
Umemura, Takeji, Satoru Joshita, Tomoo Yamazaki, et al.. (2016). Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis. Liver International. 37(6). 897–905. 18 indexed citations
5.
Verheul, Marije K., E. W. Nivine Levarht, Johan J. van der Reijden, et al.. (2016). Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies. European Journal of Gastroenterology & Hepatology. 29(3). 345–348. 6 indexed citations
6.
Zuily, Stéphane, Bas de Laat, Hilde Kelchtermans, et al.. (2015). Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study. Lara D. Veeken. 54(11). 2071–2075. 48 indexed citations
7.
Lakatos, Péter L., Nóra Sipeki, György Kovács, et al.. (2015). Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease. Journal of Crohn s and Colitis. 9(10). 891–898. 10 indexed citations
8.
Leja, Mārcis, Zakera Shums, Liene Ņikitina-Zaķe, et al.. (2015). Prevalence estimation of celiac disease in the general adult population of Latvia using serology and HLA genotyping. United European Gastroenterology Journal. 3(2). 190–199. 11 indexed citations
9.
Amengual, Olga, Tetsuya Horita, Walter L. Binder, et al.. (2014). Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies. Rheumatology International. 34(9). 1225–1230. 5 indexed citations
10.
Pavlidis, Polychronis, Zakera Shums, Andreas Koutsoumpas, et al.. (2014). Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA. Clinica Chimica Acta. 441. 176–181. 23 indexed citations
11.
Pregnolato, Francesca, Cecilia Beatrice Chighizola, Susan Encabo, et al.. (2013). Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?. Immunologic Research. 56(2-3). 432–438. 51 indexed citations
12.
Mullen, Michael T., Steven R. Messé, Scott E. Kasner, et al.. (2012). Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort. Frontiers in Neurology. 3. 137–137. 22 indexed citations
13.
Nalli, Cecilia, Laura Andréoli, Mario Motta, et al.. (2011). Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1. Reumatismo. 63(2). 91–6. 1 indexed citations
14.
Montaño‐Loza, Aldo J., Zakera Shums, Gary L. Norman, & Albert J. Czaja. (2011). Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis. Liver International. 32(1). 85–92. 61 indexed citations
15.
16.
Papp, Mária, Zsuzsanna Vitális, István Tornai, et al.. (2010). M1675 Presence of Anti-Microbial Antibodies is Associated With Increased Risk for Systemic Infections in a Large Hungarian Cohort of Patients With Liver Cirrhosis. Gastroenterology. 138(5). S–827. 2 indexed citations
17.
Norman, Gary L., Andrzej Białek, Susan Encabo, et al.. (2009). Is prevalence of PBC underestimated in patients with systemic sclerosis?. Digestive and Liver Disease. 41(10). 762–764. 23 indexed citations
18.
Milkiewicz, Piotr, et al.. (2009). Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease. Clinical Gastroenterology and Hepatology. 7(12). 1355–1360. 36 indexed citations
19.
Liaskos, Christos, Dimitrios P. Bogdanos, Nikolaos Gatselis, et al.. (2007). [452] CHRONIC HEPATITIS C IS CHARACTERISED BY AN. Journal of Hepatology. 46. S172–S172. 1 indexed citations
20.
Montaño‐Loza, Aldo J., Albert J. Czaja, Herschel A. Carpenter, et al.. (2006). Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis. Autoimmunity. 39(4). 341–348. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Johanet Breakdown of academic impact, for papers by Dominique Cazals‐Hatem Breakdown of academic impact, for papers by Giuseppe Monti Breakdown of academic impact, for papers by Marcella Visentini Breakdown of academic impact, for papers by Allison Luo Breakdown of academic impact, for papers by Laura Gragnani Breakdown of academic impact, for papers by Ibtissem Ghédira Breakdown of academic impact, for papers by Vaidehi Chowdhary Breakdown of academic impact, for papers by Juan Putra Breakdown of academic impact, for papers by J R Goepel
Rankless by CCL
2026